Greg Falls, PhD

Head of Immunotoxicology

Greg brings toxicology expertise to the Cell and Gene Therapy Development teams at Precision. He started in the pharma industry at DuPont Pharmaceuticals and Bristol-Myers Squibb, followed by over a decade at GlaxoSmithKline in metabolic disease and anti-viral drug development within the Investigative Toxicology and Pathology department. His research focused on structural cardiotoxicity and he contributed to working groups within the Health and Environmental Sciences Institute, the Predictive Safety Testing Consortium, and the Harvard Stem Cell Institute. He earned his PhD in Toxicology from North Carolina State University and completed his post-doctoral training on genomic imprinting at the Duke University Medical Center. Greg is a Diplomate of the American Board of Toxicology and Editorial Board member of Toxicological Sciences. When he is not at Precision, Greg enjoys spending time with his family, fishing and kayaking, and going to high school and college football games.